New #KCE report on Compulsory licensing for #expensive medicines: #legal environment and #economic consequences #compulsorylicensing #expensivemedicines #KULeuven Clinical Pharmacology & Pharmacotherapy, KU Leuven

Findings of the new #KCE report on “Compulsory licensing for #expensive medicines: #legal environment and #economic consequences”, to which we Clinical Pharmacology & Pharmacotherapy, KU Leuven contributed, discussed now in De Tijd De Tijd 🗞♻️ #compulsorylicensing #dwanglicenties #expensivemedicines #news #press

Artículo firmado por investigadores de la Universidad de Leuven Liese Barbier (Bélgica) con recomendaciones para implantar una política de promoción de #Biosimilares. La metodología: Técnica de Grupo Nominal. Las acciones de mayor grado de consenso y alta prioridad son👇

#biosimilarapprovals #update

Very much looking forward to speak at the European Commission’s Multistakeholder Event on #Biosimilar Medicines, next week Tue 13/12! 🇪🇺 More info and registration via link 👇 health.ec.europa.eu/latest-updates… #competition #sustainability #interchangeability MABEL Fund Clinical Pharmacology & Pharmacotherapy, KU Leuven

Interested in the regulatory landscape of electronic informed consent in clinical research? Read all about it here: bmchealthservres.biomedcentral.com/articles/10.11… #openaccess #electronicinformedconsent #decentralizedclinicaltrials #digitalhealthcare #regulatoryscience

The ISPOR Biosimilars Special Interest Group (SIG) published a new article, titled “Opening Up a Discussion on Biosimilar Value Assessment”, in the March/April 2023 issue of Value & Outcomes Spotlight. View it here: ow.ly/SzGC50NOjpJ #HEOR #biosimilars #valueassessment

✅📢Call for papers! Regulatory Science: Addressing Uncertainties in Medicines Development, Evaluation and Use Edited by Rosanne Janssens Liese Barbier (Clinical Pharmacology & Pharmacotherapy, KU Leuven) & @carla_Mtorre ➡️Find out more & submit here fro.ntiers.in/Q3v8 #clinicaltrial #regulatoryevaluation

📣 We launched a new special topic in Frontiers - Medicine now open for article submissions ✅ ⏭Regulatory Science: Addressing Uncertainties in Medicines Development, Evaluation and Use. #uncertainty #drugdevelopment #evaluation #management #communication #strategies Carla Torre

📢 New vacancy! We are looking for an enthusiastic Dutch-speaking PhD researcher to investigate ethical and societal challenges of #genetherapy in cardiomyopathy #stakeholderperspectives #mixedmethodsresearch #recruiting #PhDvacancy Interested? Find out more here:

📢 New vacancy! We are looking for an enthusiastic PhD researcher to investigate stakeholder perspectives challenges on #genetherapy in cardiomyopathy #stakeholderperspectives #mixedmethodsresearch #recruiting #PhDvacancy Interested? Find out more via the link below